Search results
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival:...
Medical Xpress· 2 days agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
Udenyca: Side effects and what to do about them
Medical News Today· 16 hours agoUdenyca is a prescription drug used to help prevent infection with chemotherapy. Learn about the serious side effects it can cause and how to manage...
Researchers discover new target for potential leukemia therapy
Medical Xpress· 3 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 4 days agoThe study aimed to determine the efficacy of uproleselan in improving survival rates when used...
GlycoMimetics Shares Drop After Leukemia Treatment Trial Fails to Meet Primary Endpoint
Market Watch· 5 days agoBy Adriano Marchese GlycoMimetics shares were sharply lower in premarket trading on Monday after the company said its drug to treat a form of acute myeloid...
Philadelphia jury awards former mechanic $725.5M in Exxon Mobil case
Philly.com· 13 hours agoA Philadelphia jury sided against Exxon Mobil Corp. and awarded $725.5 million on Thursday to a...
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 3 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
Curis to Present Updated Data from the TakeAim Leukemia Study
WPRI Providence· 17 hours ago(NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will present ...
Red carpet with a cause: This fashion show fundraiser helps kids with cancer
The Bergen Record via Yahoo News· 2 days ago“He’s really happy and very thankful for everyone who helped him,” Peña said. Most proceeds from...
Earnings call: Kura Oncology reports on ziftomenib's progress By Investing.com
Investing.com· 4 days agoZiftomenib has received Breakthrough Therapy designation from the FDA for the treatment of...